METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
Clinical trials for METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New strategy aims to keep advanced prostate cancer in check longer
Disease control OngoingThis study is testing whether a flexible, 'adaptive' approach to hormone therapy, combined with a chemotherapy drug called docetaxel, can help men with advanced prostate cancer stay responsive to standard hormone treatments for a longer period. The goal is to delay the cancer's p…
Matched conditions: METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for men with spreading prostate cancer: major trial tests powerful drug duo
Disease control OngoingThis large, late-stage trial is testing whether adding a drug called niraparib to standard hormone therapy works better for controlling advanced prostate cancer that has spread. It is for men whose cancer has specific genetic changes. The main goal is to see if the combination ca…
Matched conditions: METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC